Overview
Oat allergenic extract is used in allergenic testing.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2012/03/07 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Nelco Laboratories, Inc. | 36987-1570 | INTRADERMAL, SUBCUTANEOUS | 0.05 g in 1 mL | 12/9/2009 | |
Allergy Laboratories, Inc. | 54575-418 | PERCUTANEOUS, SUBCUTANEOUS | 1 g in 20 mL | 3/15/2011 | |
Nelco Laboratories, Inc. | 36987-1573 | INTRADERMAL, SUBCUTANEOUS | 0.1 g in 1 mL | 12/9/2009 | |
Nelco Laboratories, Inc. | 36987-1572 | INTRADERMAL, SUBCUTANEOUS | 0.1 g in 1 mL | 12/9/2009 | |
Antigen Laboratories, Inc. | 49288-0334 | SUBCUTANEOUS, INTRADERMAL | 0.05 g in 1 mL | 11/17/2009 | |
Uriel Pharmacy Inc | 48951-2137 | ORAL | 3 [hp_X] in 1 mL | 5/28/2025 | |
Nelco Laboratories, Inc. | 36987-1571 | INTRADERMAL, SUBCUTANEOUS | 0.05 g in 1 mL | 12/9/2009 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
AVEENO CLEANSING BAR - COMBINATION SKIN -38% | s.c. johnson and son, ltd. | 02163047 | Soap Bar - Topical | 38 % | 12/31/1995 |
ADAPTAGEN | bio active canada ltd. | 02233546 | Liquid - Oral | 3 X | 5/26/1998 |
AVEENO CLEANSING BAR OILATED FORMULA 51% | s.c. johnson and son, ltd. | 00652334 | Soap Bar - Topical | 51 % | 12/31/1990 |
AVEENO N.S. COLLOIDAL OATMEAL&M.O.B.T.-PWR | s.c. johnson and son, ltd. | 02149044 | Powder - Topical | 43.3 % | 12/31/1951 |
JUNIPLEX I | bio active canada ltd. | 02233640 | Liquid - Oral | 1 X | 5/26/1998 |
HOMEO-FORM ST-LIQ | homeocan inc. | 02140667 | Liquid - Oral | 3 X / ML | 12/31/1995 |
ACIDUM PHOSPHORICUM PLEX | seroyal international inc. | 02233076 | Pellet
,
Tablet
,
Drops
,
Syrup
,
Granules
,
Liquid - Oral | 1 X | 4/6/1998 |
APIZELEN | bio active canada ltd. | 02233553 | Liquid - Oral | 1 C | 5/26/1998 |
THC COMPLEX #71 | total health centre | 02236390 | Drops - Oral | 1 X | 3/29/1998 |
TOBTOX | bio active canada ltd. | 02233688 | Liquid - Oral | 1 X | 5/26/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.